US 10233174
Thiocarbamate prodrugs of tofacitinib
granted A61KA61K31/7028A61P
Quick answer
US patent 10233174 (Thiocarbamate prodrugs of tofacitinib) held by Theravance Biopharma R&D IP, LLC expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/7028, A61P, A61P1/00, A61P1/04